Superficial dedifferentiated liposarcoma: A clinicopathologic study

Hum Pathol. 2024 Mar:145:63-70. doi: 10.1016/j.humpath.2024.02.008. Epub 2024 Feb 27.

Abstract

Introduction: Dedifferentiation occurs in approximately 10% of atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLPS), primarily in retroperitoneal or deep-seated tumors, conferring metastatic potential. Superficial dedifferentiated liposarcoma (sDDLPS) is rare, and its progression and natural history are poorly documented.

Methods: We performed a 15-year retrospective review of our pathology database to identify cases of DDLPS in the skin or subcutaneous tissue. Diagnosis of primary sDDLPS required evidence of non-lipogenic sarcoma in the skin or subcutis, with concurrent ALT/WDLPS and/or MDM2 amplification.

Results: We identified 14 cases of DDLPS involving skin or subcutis: 7 primary sDDLPS and 7 secondary lesions (3 from recurrent deep DDLPS and 4 from metastasis). Primary sDDLPS cases (4 females, 3 males; median age: 74) mainly presented as undifferentiated spindle cell or pleomorphic sarcoma. Tumor grades were grade 2 (5 cases) and grade 3 (2 cases), with three cases also showing grade 1 areas. MDM2 amplification was confirmed in 6 sDDLPSs for which FISH was successfully performed. Follow-up available for 6 sDDLPS patients showed 2 local recurrences, treated with re-excision and radiation therapy, with all disease-free at last follow-up (5-126 months). Of the 7 secondary cases, 2 had ongoing disease after multiple recurrences, 1 was disease-free, and all 4 with cutaneous metastasis died of disease (follow-up range: 24-263 months).

Conclusion: These findings emphasize the importance of distinguishing between primary sDDLPS and secondary lesions due to their distinct prognoses. Metastasis or superficial extensions from deep DDLP correlate with a considerably worse prognosis than those originating in superficial tissues.

Keywords: Dedifferentiation; MDM2; Superficial pleomorphic sarcoma; Well-differentiated liposarcoma.

MeSH terms

  • Aged
  • Female
  • Humans
  • Lipoma*
  • Liposarcoma* / genetics
  • Male
  • Proto-Oncogene Proteins c-mdm2 / genetics
  • Sarcoma*
  • Skin
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / therapy

Substances

  • Proto-Oncogene Proteins c-mdm2